Wealthspire Advisors (New York)’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.2M | Buy |
4,104
+46
| +1% | +$24.7K | 0.01% | 266 |
|
|
2025
Q1 | $1.7M | Buy |
4,058
+79
| +2% | +$33.2K | 0.01% | 297 |
|
|
2024
Q4 | $1.65M | Sell |
3,979
-1,358
| -25% | -$561K | 0.02% | 275 |
|
|
2024
Q3 | $2.7M | Sell |
5,337
-25
| -0.5% | -$12.6K | 0.03% | 206 |
|
|
2024
Q2 | $2.61M | Buy |
5,362
+2,930
| +120% | +$1.43M | 0.03% | 172 |
|
|
2024
Q1 | $1.31M | Sell |
2,432
-25
| -1% | -$13.5K | 0.02% | 269 |
|
|
2023
Q4 | $1.36M | Buy |
2,457
+692
| +39% | +$384K | 0.02% | 260 |
|
|
2023
Q3 | $772K | Buy |
1,765
+7
| +0.4% | +$3.06K | 0.01% | 320 |
|
|
2023
Q2 | $883K | Sell |
1,758
-21
| -1% | -$10.5K | 0.01% | 270 |
|
|
2023
Q1 | $890K | Sell |
1,779
-221
| -11% | -$111K | 0.02% | 268 |
|
|
2022
Q4 | $816K | Buy |
2,000
+187
| +10% | +$76.3K | 0.01% | 297 |
|
|
2022
Q3 | $591K | Sell |
1,813
-49
| -3% | -$16K | 0.01% | 304 |
|
|
2022
Q2 | $653K | Buy |
1,862
+155
| +9% | +$54.4K | 0.01% | 281 |
|
|
2022
Q1 | $934K | Buy |
1,707
+230
| +16% | +$126K | 0.02% | 198 |
|
|
2021
Q4 | $973K | Sell |
1,477
-175
| -11% | -$115K | 0.02% | 230 |
|
|
2021
Q3 | $1.03M | Buy |
1,652
+462
| +39% | +$287K | 0.02% | 242 |
|
|
2021
Q2 | $752K | Sell |
1,190
-365
| -23% | -$231K | 0.02% | 186 |
|
|
2021
Q1 | $761K | Buy |
1,555
+228
| +17% | +$112K | 0.02% | 308 |
|
|
2020
Q4 | $663K | Sell |
1,327
-2,787
| -68% | -$1.39M | 0.02% | 261 |
|
|
2020
Q3 | $1.62M | Buy |
4,114
+50
| +1% | +$19.7K | 0.1% | 98 |
|
|
2020
Q2 | $1.34M | Sell |
4,064
-3,283
| -45% | -$1.08M | 0.09% | 91 |
|
|
2020
Q1 | $1.78M | Buy |
7,347
+5,250
| +250% | +$1.27M | 0.07% | 136 |
|
|
2019
Q4 | $548K | Buy |
2,097
+67
| +3% | +$17.5K | 0.04% | 97 |
|
|
2019
Q3 | $552K | Buy |
+2,030
| New | +$552K | 0.05% | 81 |
|
|
2019
Q1 | – | Sell |
-423
| Closed | -$79K | – | 392 |
|
|
2018
Q4 | $79K | Buy |
+423
| New | +$79K | 0.01% | 129 |
|